📊 Q3 Earnings are here! Plan ahead with key data on upcoming stock reports - all in 1 placeSee list

Castlight (CSLT) To Report Q4 Earnings:What's In The Cards?

Published 02/19/2018, 10:11 PM
Updated 07/09/2023, 06:31 AM
ADI
-
EFX
-
MU
-
GOGO
-
CSLT
-

Castlight Health, Inc. (NYSE:CSLT) is set to report fourth-quarter 2017 results on Feb 21.

Notably, the company has beaten the Zacks Consensus Estimate is the trailing four quarters, with an average positive surprise of 40.54%. Last quarter, the company came up with a positive surprise of 28.57%.

Loss of 5 cents per share was in line with the year-ago quarter figure. Revenues increased 35.6% year over year to $34.6 million and also surpassed the Zacks Consensus Estimate of $34 million. Castlight stated that increasing rate of adoption, broadening product portfolio and operating efficiencies were the key catalysts.

Factors to Consider

Castlight’s software platform that assists organizations in gaining control over their health care costs is witnessing rapid adoption. This was evident from the top-line growth. Moreover, Castlight expects renewals to boost its annualized recurring revenues (“ARR”).

The Zacks Consensus Estimate for Professional Services segment revenues is around $3.2 million while that for Subscription revenues is about $33.1 million.

The company’s strategic acquisition of Jiff has strengthened its product portfolio. Cross-selling of products is also expanding customer base.

Moreover, partnerships with the likes of Livongo, Big Health, Hinge Health, Retrofit and Kurbo are likely to help the company rapidly penetrate a number of health markets. Additionally, integration of Castlight's comprehensive health navigation platform with Washington Health Alliance will expand customer base.

We believe all these factors to be key catalysts for the company’s fourth-quarter results. The Zacks Consensus Estimate for revenues and earnings are $36 million and negative 4 cents per share, respectively.

What Our Model Says

According to the Zacks model, a company with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) has a good chance of beating estimates if it also has a positive Earnings ESP. The Sell-rated stocks (Zacks Rank #4 or 5) are best avoided. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Castlight has a Zacks Rank #3 and an Earnings ESP of +7.69%. Consequently, our proven model shows that the company is likely to deliver a positive surprise this quarter.

Other Stocks to Consider

Here are some other top-ranked stocks that you may want to consider as our model shows that these too have the right combination of elements to deliver an earnings beat in their upcoming release.

Micron Technology (NASDAQ:MU) has an Earnings ESP of +1.83% and a Zacks Rank #3. You can see the complete list of today’s Zacks #1 Rank stocks here.

Analog Devices (NASDAQ:ADI) has an Earnings ESP of +0.96% and a Zacks Rank #3.

Gogo Inc. (NASDAQ:GOGO) has an Earnings ESP of +2.80% and a Zacks Rank #3.

Can Hackers Put Money INTO Your Portfolio?

Earlier this month, credit bureau Equifax (NYSE:EFX) announced a massive data breach affecting 2 out of every 3 Americans. The cybersecurity industry is expanding quickly in response to this and similar events. But some stocks are better investments than others.

Zacks has just released Cybersecurity! An Investor’s Guide to help Zacks.com readers make the most of the $170 billion per year investment opportunity created by hackers and other threats. It reveals 4 stocks worth looking into right away.

Download the new report now>>



Castlight Health, inc. (CSLT): Free Stock Analysis Report

Gogo Inc. (GOGO): Free Stock Analysis Report

Analog Devices, Inc. (ADI): Free Stock Analysis Report

Micron Technology, Inc. (MU): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.